Favaloro Cardiovascular Symposium 2025

The Latin American Society of Interventional Cardiology invites you to participate in the Favaloro Cardiovascular Symposium 2025, which will take place from September 11 to 12, 2025, at the Intercontinental Hotel in Buenos Aires, Argentina.

The event is endorsed by SOLACI and will feature a rich and diverse scientific program. Various scientific activities, simultaneous sessions, and live case transmissions from Rotterdam and the Favaloro Hospital will be conducted. Topics will range from prevention to heart transplantation, always highlighting the latest innovations and technological advances.

Additionally, distinguished professors from around the world will join to share their knowledge with the audience.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

SOLACI Webinar for Nurses and Technicians | Cardiovascular Risk Factors in Women

Cardiovascular disease remains the leading cause of death in women. Do we truly understand its risk factors and warning signs? 📢 We invite you to...

SOLACI Session at Miami Valves 2026

Once again, the Latin American Society of Interventional Cardiology will be present at one of the most important congresses worldwide in the field, with...

Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition

Registration is now open for the SOLACI–CACI Advanced Postgraduate Course in Hemodynamics and Interventional Cardiology – 2026 Edition. The program is intended for physicians with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TEER plus optimal medical therapy versus medical therapy alone in functional mitral regurgitation

Mitral regurgitation (MR) is a highly prevalent valvular heart disease that, in advanced stages and when left untreated, is associated with reduced quality of...

Hybrid Coronary Revascularization versus Conventional Bypass Surgery in Left Main Coronary Artery Disease

Significant left main coronary artery (LMCA) disease continues to represent a therapeutic challenge, particularly in patients with complex multivessel disease and high SYNTAX scores,...

VECTOR: First Percutaneous Aorto-Coronary Bypass Case, a New Conceptual Approach

Coronary obstruction represents one of the most severe complications associated with transcatheter aortic valve implantation, particularly in valve-in-valve scenarios involving surgical bioprostheses, narrow aortic...